Echo Therapeutics, Inc. (ECTE) Stock Analysis
DELISTED 2016
What happened to Echo Therapeutics, Inc. (ECTE) stock?
Echo Therapeutics, Inc. (ECTE) no longer trades on public markets. It was delisted in July 2016. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- July 2016
- Last recorded price (historical):
- $0.0002 (last quote on record before the July 2016 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Echo Therapeutics, Inc. (ECTE). Echo Therapeutics, Inc. is focused on developing transdermal skin permeation and diagnostic medical devices. Their primary focus is a needle-free wireless continuous glucose monitoring (CGM) system.
Last analyzed: Mar 17, 2026Echo Therapeutics, Inc. (ECTE) Healthcare & Pipeline Overview
ECTE OTC Market Information
ECTE trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy ECTE shares?
No. ECTE stopped trading on public markets in July 2016, so the shares are not available through a broker. Anything you see quoted for ECTE elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ECTE stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Echo Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.